Sarabia, Arnold N.
HRN: 25-25-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2024
LEVOFLOXACIN 500MG (TAB)
06/28/2024
07/12/2024
PO
500mg
OD
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes